|
| 37831068 | RNF185 Control of COL3A1 Expression Limits Prostate Cancer Migration and Metastatic Potential. | Mol Cancer Res | 2024 |
| 37831068 | RNF185 Control of COL3A1 Expression Limits Prostate Cancer Migration and Metastatic Potential. | Mol Cancer Res | 2024 |
| 36513937 | Immunohistochemical Techniques for Phosphoproteins. | Methods Mol Biol | 2023 |
| 37961717 | YAP-Driven Malignant Reprogramming of Epithelial Stem Cells at Single Cell Resolution. | Res Sq | 2023 |
| 37858338 | High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma. | Cell Rep Med | 2023 |
| 36513937 | Immunohistochemical Techniques for Phosphoproteins. | Methods Mol Biol | 2023 |
| 37078793 | Ubiquitin Ligases Siah1a/2 Control Alveolar Macrophage Functions to Limit Carcinogen-Induced Lung Adenocarcinoma. | Cancer Res | 2023 |
| 37425866 | RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential. | bioRxiv | 2023 |
| 37546810 | Direct reprogramming of oral epithelial progenitor cells to cancer stem cells at single cell resolution <i>in vivo</i>. | bioRxiv | 2023 |
| 37961717 | YAP-Driven Malignant Reprogramming of Epithelial Stem Cells at Single Cell Resolution. | Res Sq | 2023 |
| 37858338 | High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma. | Cell Rep Med | 2023 |
| 37546810 | Direct reprogramming of oral epithelial progenitor cells to cancer stem cells at single cell resolution <i>in vivo</i>. | bioRxiv | 2023 |
| 37425866 | RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential. | bioRxiv | 2023 |
| 37078793 | Ubiquitin Ligases Siah1a/2 Control Alveolar Macrophage Functions to Limit Carcinogen-Induced Lung Adenocarcinoma. | Cancer Res | 2023 |
| 34935137 | Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1. | Int J Cancer | 2022 |
| 35879302 | Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC. | Nat Commun | 2022 |
| 35790753 | Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy. | Nat Commun | 2022 |
| 35467979 | Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis. | Proc Natl Acad Sci U S A | 2022 |
| 33723406 | The molecular underpinning of geminin-overexpressing triple-negative breast cancer cells homing specifically to lungs. | Cancer Gene Ther | 2022 |
| 34935137 | Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1. | Int J Cancer | 2022 |
| 35467979 | Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis. | Proc Natl Acad Sci U S A | 2022 |
| 35790753 | Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy. | Nat Commun | 2022 |
| 35879302 | Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC. | Nat Commun | 2022 |
| 33723406 | The molecular underpinning of geminin-overexpressing triple-negative breast cancer cells homing specifically to lungs. | Cancer Gene Ther | 2022 |
| 33096435 | Detecting cancer metastasis and accompanying protein biomarkers at single cell levels using a 3D-printed microfluidic immunoarray. | Biosens Bioelectron | 2021 |
| 33958486 | Progesterone promotes immunomodulation and tumor development in the murine mammary gland. | J Immunother Cancer | 2021 |
| 33888713 | Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer. | Nat Commun | 2021 |
| 33989559 | Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial. | Lancet Oncol | 2021 |
| 34255745 | Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions. | JCI Insight | 2021 |
| 33603171 | Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis. | Oncogene | 2021 |
| 33926206 | Potential Use of College of American Pathologists Accredited Biorepositories to Bridge Unmet Need for Medical Refrigeration Using Ultralow Temperature Storage for COVID-19 Vaccine or Drug Storage. | Biopreserv Biobank | 2021 |
| 34348031 | Vulnerabilities of Cancer Patients and Their Effects on Informed Consent for Biobanking. | Biopreserv Biobank | 2021 |
| 33096435 | Detecting cancer metastasis and accompanying protein biomarkers at single cell levels using a 3D-printed microfluidic immunoarray. | Biosens Bioelectron | 2021 |
| 33359448 | The anti-tumour activity of DNA methylation inhibitor 5-aza-2'-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress. | Cancer Lett | 2021 |
| 33603171 | Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis. | Oncogene | 2021 |
| 33926206 | Potential Use of College of American Pathologists Accredited Biorepositories to Bridge Unmet Need for Medical Refrigeration Using Ultralow Temperature Storage for COVID-19 Vaccine or Drug Storage. | Biopreserv Biobank | 2021 |
| 33888713 | Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer. | Nat Commun | 2021 |
| 33989559 | Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial. | Lancet Oncol | 2021 |
| 34348031 | Vulnerabilities of Cancer Patients and Their Effects on Informed Consent for Biobanking. | Biopreserv Biobank | 2021 |
| 33958486 | Progesterone promotes immunomodulation and tumor development in the murine mammary gland. | J Immunother Cancer | 2021 |
| 34255745 | Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions. | JCI Insight | 2021 |
| 33359448 | The anti-tumour activity of DNA methylation inhibitor 5-aza-2'-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress. | Cancer Lett | 2021 |
| 31626727 | Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer. | Cancer | 2020 |
| 32178638 | Age-related differences in breast cancer mortality according to race/ethnicity, insurance, and socioeconomic status. | BMC Cancer | 2020 |
| 32302515 | Cryopreservation of Viable Human Tissues: Renewable Resource for Viable Tissue, Cell Lines, and Organoid Development. | Biopreserv Biobank | 2020 |
| 31626727 | Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer. | Cancer | 2020 |
| 32848210 | HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers. | Oncogene | 2020 |
| 32727882 | Tipifarnib as a Precision Therapy for <i>HRAS</i>-Mutant Head and Neck Squamous Cell Carcinomas. | Mol Cancer Ther | 2020 |
| 32944296 | Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer. | Cancers Head Neck | 2020 |
| 32944296 | Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer. | Cancers Head Neck | 2020 |